<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65757">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02249819</url>
  </required_header>
  <id_info>
    <org_study_id>14-416</org_study_id>
    <nct_id>NCT02249819</nct_id>
  </id_info>
  <brief_title>Evaluating Anodal tDCS Preceding Aphasia Therapy</brief_title>
  <official_title>Evaluating Anodal tDCS Preceding Aphasia Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if non-invasive brain stimulation (transcranial
      direct current stimulation) delivered prior to language therapy will improve word-finding in
      individuals with aphasia who are 6 months or greater post-stroke.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in picture-word matching accuracy of trained items</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in picture-word matching accuracy of untrained items</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Western Aphasia Battery</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Stroke</condition>
  <condition>Aphasia</condition>
  <arm_group>
    <arm_group_label>tDCS stimulation followed by aphasia therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 min of anodal tDCS followed by computerized naming therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS stimulation followed by aphasia therapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 min of sham tDCS followed by computerized naming therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <description>Soterix 1x1 anodal tDCS</description>
    <arm_group_label>tDCS stimulation followed by aphasia therapy</arm_group_label>
    <arm_group_label>sham tDCS stimulation followed by aphasia therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. â‰¥ 18 years of age

          2. First single focal unilateral left hemisphere lesion with diagnosis verified by brain
             imaging (MRI or CT scans) that occurred at least 6 months prior

          3. Pre-morbidly right handed

          4. Pre-morbidly fluent English speaker

          5. Cognitive function sufficient to understand the experiments and follow instructions
             (per interview with Speech Pathologist)

          6. A baseline Aphasia Quotient score between 10 to 94 out of 100 points on the Western
             Aphasia Battery (neither completely without language comprehension/expression nor
             fully recovered from aphasia).

        Exclusion Criteria:

          1. Ongoing use of CNS-active medications

          2. Ongoing use of psychoactive medications, such as stimulants, antidepressants, and
             anti-psychotic medications

          3. Presence of additional potential tDCS risk factors:

               -  Damaged skin at the site of stimulation (i.e., skin with ingrown hairs, acne,
                  razor nicks, wounds that have not healed, recent scar tissue, broken skin, etc.)

               -  Presence of an electrically, magnetically or mechanically activated implant
                  (including cardiac pacemaker), an intracerebral vascular clip, or any other
                  electrically sensitive support system

               -  Metal in any part of the body, including metal injury to the eye (jewelry must
                  be removed during stimulation)

               -  A history of medication-resistant epilepsy in the family

               -  Past history of seizures or unexplained spells of loss of consciousness during
                  the previous 36 months

          4. Pregnancy in women, as determined by self-report
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Johanna L Chang, MS, CCC-SLP</last_name>
    <phone>516-562-3646</phone>
    <email>jchang14@nshs.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bruce T Volpe, MD</last_name>
    <phone>516-562-3384</phone>
    <email>bvolpe1@nshs.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Feinstein Institute for Medical Research</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Monti A, Cogiamanian F, Marceglia S, Ferrucci R, Mameli F, Mrakic-Sposta S, Vergari M, Zago S, Priori A. Improved naming after transcranial direct current stimulation in aphasia. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):451-3. Epub 2007 Dec 20.</citation>
    <PMID>18096677</PMID>
  </reference>
  <reference>
    <citation>Baker JM, Rorden C, Fridriksson J. Using transcranial direct-current stimulation to treat stroke patients with aphasia. Stroke. 2010 Jun;41(6):1229-36. doi: 10.1161/STROKEAHA.109.576785. Epub 2010 Apr 15.</citation>
    <PMID>20395612</PMID>
  </reference>
  <reference>
    <citation>Fiori V, Coccia M, Marinelli CV, Vecchi V, Bonifazi S, Ceravolo MG, Provinciali L, Tomaiuolo F, Marangolo P. Transcranial direct current stimulation improves word retrieval in healthy and nonfluent aphasic subjects. J Cogn Neurosci. 2011 Sep;23(9):2309-23. doi: 10.1162/jocn.2010.21579. Epub 2010 Oct 14.</citation>
    <PMID>20946060</PMID>
  </reference>
  <reference>
    <citation>Holland R, Crinion J. Can tDCS enhance treatment of aphasia after stroke? Aphasiology. 2012 Sep;26(9):1169-1191. Epub 2011 Nov 3.</citation>
    <PMID>23060684</PMID>
  </reference>
  <reference>
    <citation>Marangolo P, Fiori V, Campana S, Calpagnano MA, Razzano C, Caltagirone C, Marini A. Something to talk about: enhancement of linguistic cohesion through tdCS in chronic non fluent aphasia. Neuropsychologia. 2014 Jan;53:246-56. doi: 10.1016/j.neuropsychologia.2013.12.003. Epub 2013 Dec 11.</citation>
    <PMID>24333381</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 22, 2016</lastchanged_date>
  <firstreceived_date>September 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwell Health</investigator_affiliation>
    <investigator_full_name>Bruce Volpe</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>aphasia</keyword>
  <keyword>CVA</keyword>
  <keyword>apraxia</keyword>
  <keyword>cerebrovascular accident</keyword>
  <keyword>cerebral stroke</keyword>
  <keyword>speech therapy</keyword>
  <keyword>aphasia therapy</keyword>
  <keyword>non-invasive brain stimulation</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>tDCS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Aphasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
